Skip to playerSkip to main contentSkip to footer
  • 2/16/2018
Y K Hamied, from Cipla talks about the key triggers for Cipla to go global and shares his thoughts on the monopoly regime in the country that has stopped the company to manufacture many drugs here

Recommended